Next Financial Group’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$2K Buy
25
+7
+39% +$474 ﹤0.01% 2612
2021
Q3
$1K Hold
18
﹤0.01% 2627
2021
Q2
$1K Buy
18
+6
+50% +$424 ﹤0.01% 2529
2021
Q1
$1K Buy
+12
New +$813 ﹤0.01% 2421
2020
Q1
Sell
-251
Closed -$15K 2243
2019
Q4
$15K Hold
251
﹤0.01% 1622
2019
Q3
$15K Hold
251
﹤0.01% 1550
2019
Q2
$14K Buy
+251
New +$12.9K ﹤0.01% 1582
2019
Q1
Sell
-251
Closed -$11K 1843
2018
Q4
$11K Buy
+251
New +$13.8K ﹤0.01% 1311
2017
Q1
Sell
-250
Closed -$11K 2056
2016
Q4
$11K Hold
250
﹤0.01% 1602
2016
Q3
$10K Buy
+250
New +$10.5K ﹤0.01% 1648
2014
Q4
Sell
-306
Closed -$6K 2100
2014
Q3
$6K Hold
306
﹤0.01% 1981
2014
Q2
$6K Buy
+306
New +$5.7K ﹤0.01% 881

Other funds holding IART

Next Financial Group's IART Position: Q4 2021 in Review

Next Financial Group increased its Integra LifeSciences (IART) stake by 39% in Q4 2021, buying an estimated $474 and bringing the position to 25 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #2612.

Next Financial Group first reported a position in IART in Q2 2014 and has held it in 12 quarters since. The position peaked at $15K in Q4 2019. 277 funds tracked by Wall St. Rank hold IART as of Q4 2021.

  • Next Financial Group held 25 shares of Integra LifeSciences worth $2K as of Q4 2021.
  • Next Financial Group bought 7 Integra LifeSciences shares in Q4 2021, an estimated $474.
  • Integra LifeSciences made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2612 holding.
  • Next Financial Group first reported a position in Integra LifeSciences in Q2 2014 and has held it in 12 quarters since.
  • Next Financial Group's Integra LifeSciences position peaked at $15K in Q4 2019.
  • 277 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.